Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gold | 2 | 2024 | 57 | 0.870 |
Why?
|
| Theranostic Nanomedicine | 2 | 2021 | 7 | 0.860 |
Why?
|
| Graphite | 2 | 2021 | 14 | 0.840 |
Why?
|
| Doxorubicin | 2 | 2024 | 303 | 0.800 |
Why?
|
| Silicon Dioxide | 1 | 2021 | 31 | 0.700 |
Why?
|
| Phototherapy | 1 | 2020 | 39 | 0.660 |
Why?
|
| Liposomes | 1 | 2020 | 207 | 0.620 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 252 | 0.590 |
Why?
|
| Brain Diseases | 1 | 2020 | 310 | 0.550 |
Why?
|
| Neoplasms | 3 | 2021 | 3035 | 0.540 |
Why?
|
| Cancer Survivors | 1 | 2020 | 251 | 0.530 |
Why?
|
| Hepatoblastoma | 3 | 2024 | 184 | 0.490 |
Why?
|
| Stem Cells | 1 | 2020 | 754 | 0.470 |
Why?
|
| Metal Nanoparticles | 2 | 2024 | 59 | 0.370 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 1854 | 0.360 |
Why?
|
| Quantum Dots | 2 | 2021 | 14 | 0.340 |
Why?
|
| Quality of Life | 1 | 2020 | 2163 | 0.330 |
Why?
|
| Liver Neoplasms | 3 | 2024 | 1416 | 0.280 |
Why?
|
| Nanomedicine | 1 | 2025 | 26 | 0.230 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2024 | 111 | 0.220 |
Why?
|
| Particle Size | 1 | 2024 | 148 | 0.220 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 78 | 0.190 |
Why?
|
| Pyelonephritis | 1 | 2021 | 29 | 0.180 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 3800 | 0.180 |
Why?
|
| Oxadiazoles | 1 | 2021 | 25 | 0.180 |
Why?
|
| Emphysema | 1 | 2021 | 67 | 0.170 |
Why?
|
| Infrared Rays | 1 | 2020 | 24 | 0.170 |
Why?
|
| 3T3 Cells | 1 | 2020 | 127 | 0.170 |
Why?
|
| Nanotechnology | 1 | 2020 | 51 | 0.170 |
Why?
|
| Diabetes Complications | 1 | 2021 | 206 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 135 | 0.160 |
Why?
|
| Piperazines | 1 | 2021 | 256 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2021 | 289 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 625 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 709 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 795 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2021 | 750 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 385 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 396 | 0.110 |
Why?
|
| Humans | 11 | 2025 | 134194 | 0.100 |
Why?
|
| Mice | 4 | 2024 | 19045 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1419 | 0.090 |
Why?
|
| Animals | 5 | 2024 | 36521 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 2771 | 0.070 |
Why?
|
| Drug Liberation | 1 | 2024 | 36 | 0.060 |
Why?
|
| Materials Testing | 1 | 2024 | 77 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 65 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2024 | 127 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2025 | 233 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2024 | 318 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 91 | 0.050 |
Why?
|
| Vincristine | 1 | 2024 | 196 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 890 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 4802 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2021 | 119 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 69 | 0.040 |
Why?
|
| Global Health | 1 | 2025 | 623 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 399 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2021 | 186 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 2021 | 190 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 914 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1013 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1316 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2562 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2021 | 1032 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1945 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 1876 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 2137 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1193 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5219 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2588 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4936 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2021 | 14897 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 29413 | 0.010 |
Why?
|
| Male | 1 | 2021 | 66195 | 0.010 |
Why?
|
| Female | 1 | 2021 | 72035 | 0.010 |
Why?
|